ArticleInternational dental journal2026
An Oxygen-Releasing Mouthwash Reduces Porphyromonas gingivalis Biofilm and Suppresses fimA and hagA Expression.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsPorphyromonas gingivalis is a key periodontal pathogen whose biofilm and virulence limit the effectiveness of mouthwashes such as chlorhexidine (CHX). This study evaluated the antibacterial, antibiofilm and virulence effects of an oxygen-releasing mouthwash against P. gingivalis, complemented by in silico docking and cytotoxicity testing on human oral fibroblasts.
methodsP. gingivalis ATCC 33277 was grown anaerobically. Minimum inhibitory (MIC), bactericidal (MBC) and biofilm inhibitory concentrations (MBIC) were determined by resazurin-based microdilution and crystal violet biofilm assays, with 0.12% CHX as control. Biofilm structure and viability were analysed by confocal microscopy. Quantitative PCR measured expression of 6 virulence- and biofilm-associated genes. Molecular docking of sodium perborate to protein targets used AutoDock GNINA. Fibroblast cytotoxicity (ISO 10993-5 threshold ≥70% viability) was evaluated over 30 min to 24 h.
resultsBluem mouthwash showed concentration-dependent inhibition of P. gingivalis with minimum inhibitory (MIC), bactericidal (MBC) and biofilm inhibitory concentrations (MBIC) values of 0.78%, 1.56% and 3.12%, respectively. At 0.78%, biofilm biomass decreased to around 45% and at concentrations of ≥3.12% was reduced to ≤20%, with greater reduction than 0.12% CHX. Confocal imaging showed reduced biomass and thickness with a predominance of nonviable cells at higher concentrations. Bluem mouthwash was associated with downregulation of virulence-related genes, with fimA and hagA expression reduced at concentrations ≥0.78%, whereas 0.12% CHX increased fimA expression. Molecular docking predicted moderate binding affinities of sodium perborate with key virulence proteins, including kgp and mfa1. Bluem concentrations ≤0.78% maintained noncytotoxic fibroblast viability, while ≥1.56% and 0.12% CHX were cytotoxic across all tested periods.
conclusionThe oxygen-releasing mouthwash inhibited P. gingivalis biofilm formation, modulated virulence-associated gene expression and showed a wider noncytotoxic range on oral periodontal fibroblasts than chlorhexidine. CLINICAL RELEVANCE: These findings on an oxygen-releasing mouthwash may help guide concentration selection and inform its potential adjunctive use in periodontal protocols, but clinical outcome studies are still needed before routine use can be recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.